CLOV vs. NKE
CLOV (Clover Health Investments, Corp.) and NKE (NIKE, Inc.) are both stocks. CLOV operates in Healthcare Plans (Healthcare), while NKE operates in Footwear & Accessories (Consumer Cyclical). Over the past 5 years, CLOV returned -12.37%/yr vs -23.01%/yr for NKE. Their 0.27 correlation means their historical movements had little consistent relationship.
Performance
CLOV vs. NKE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CLOV achieves a 77.45% return, which is significantly higher than NKE's -33.51% return.
CLOV
- 1D
- -3.92%
- 1M
- -20.72%
- 6M
- 86.16%
- YTD
- 77.45%
- 1Y
- 50.00%
- 3Y*
- 47.48%
- 5Y*
- -12.37%
- 10Y*
- —
- ALL TIME*
- -13.39%
NKE
- 1D
- -1.37%
- 1M
- -5.40%
- 6M
- -31.46%
- YTD
- -33.51%
- 1Y
- -42.57%
- 3Y*
- -25.96%
- 5Y*
- -23.01%
- 10Y*
- -1.37%
- ALL TIME*
- 13.91%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $16.28M | $21.81M | $31.68M | |
NKE NIKE, Inc. | $770.61M | $804.55M | $1.00B |
CLOV vs. NKE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
CLOV Clover Health Investments, Corp. | 77.45% | -25.40% | 230.85% | 2.43% | -75.01% | -77.82% | 66.53% |
NKE NIKE, Inc. | -33.51% | -13.83% | -29.11% | -6.01% | -29.04% | 18.70% | 49.28% |
Correlation
The correlation between CLOV and NKE is 0.21, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.21 |
Correlation (3Y) Balances recent behavior with more history. | 0.20 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.30 |
Correlation (All Time) Calculated using the full available price history since Jun 12, 2020 | 0.27 |
Fundamentals
CLOV:
$2.16B
NKE:
$61.72B
CLOV:
-$0.11
NKE:
$2.10
CLOV:
0.98
NKE:
1.33
CLOV:
6.42
NKE:
1.61
CLOV:
$2.21B
NKE:
$46.40B
CLOV:
$939.14M
NKE:
$19.91B
CLOV:
-$55.21M
NKE:
$3.21B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CLOV vs. NKE — Risk / Return Rank
CLOV
NKE
CLOV vs. NKE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and NIKE, Inc. (NKE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CLOV | NKE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.84 | ||
| Sortino ratioReturn per unit of downside risk | +3.12 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 0.78 | +0.39 |
| Calmar ratioReturn relative to maximum drawdown | 0.80 | -0.91 | +1.71 |
| Martin ratioReturn relative to average drawdown | 1.50 | -1.47 | +2.96 |
Loading charts...
Drawdowns
CLOV vs. NKE - Drawdown Comparison
The maximum CLOV drawdown since its inception was -97.19%, which is greater than NKE's maximum drawdown of -75.19%. Use the drawdown chart below to compare losses from any high point for CLOV and NKE.
Loading charts...
Drawdown Indicators
| CLOV | NKE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.19% | -75.19% | -22.00% |
Max Drawdown (1Y)Largest decline over 1 year | -55.50% | -47.12% | -8.38% |
Max Drawdown (3Y)Largest decline over 3 years | -64.73% | -64.87% | +0.14% |
Max Drawdown (5Y)Largest decline over 5 years | -94.24% | -75.10% | -19.14% |
Max Drawdown (10Y)Largest decline over 10 years | — | -75.10% | — |
Current DrawdownCurrent decline from peak | -81.17% | -74.52% | -6.65% |
Average DrawdownAverage peak-to-trough decline | -76.63% | -21.08% | -55.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 29.67% | 29.10% | +0.57% |
Volatility
CLOV vs. NKE - Volatility Comparison
Clover Health Investments, Corp. (CLOV) has a higher volatility of 17.57% compared to NIKE, Inc. (NKE) at 9.03%. This indicates that CLOV's price experiences larger fluctuations and is considered to be riskier than NKE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CLOV | NKE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.57% | 9.03% | +8.54% |
Volatility (6M)Calculated over the trailing 6-month period | 43.33% | 27.78% | +15.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 70.03% | 35.45% | +34.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 76.63% | 35.54% | +41.09% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 85.26% | 32.44% | +52.82% |
Dividends
CLOV vs. NKE - Dividend Comparison
CLOV has not paid dividends to shareholders, while NKE's dividend yield for the trailing twelve months is around 3.91%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLOV Clover Health Investments, Corp. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NKE NIKE, Inc. | 3.91% | 2.53% | 2.00% | 1.28% | 1.07% | 0.68% | 0.71% | 0.89% | 1.11% | 1.18% | 1.30% | 0.93% |
Financials
CLOV vs. NKE - Financials Comparison
This section allows you to compare key financial metrics between Clover Health Investments, Corp. and NIKE, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CLOV vs. NKE - Profitability Comparison
CLOV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Clover Health Investments, Corp. reported a gross profit of 692.13M and revenue of 749.19M. Therefore, the gross margin over that period was 92.4%.
NKE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, NIKE, Inc. reported a gross profit of 5.39B and revenue of 10.97B. Therefore, the gross margin over that period was 49.2%.
CLOV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Clover Health Investments, Corp. reported an operating income of 27.33M and revenue of 749.19M, resulting in an operating margin of 3.7%.
NKE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, NIKE, Inc. reported an operating income of 1.31B and revenue of 10.97B, resulting in an operating margin of 12.0%.
CLOV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Clover Health Investments, Corp. reported a net income of 27.33M and revenue of 749.19M, resulting in a net margin of 3.7%.
NKE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, NIKE, Inc. reported a net income of 1.07B and revenue of 10.97B, resulting in a net margin of 9.7%.
Frequently Asked Questions
CLOV and NKE have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLOV has higher volatility (17.57%) compared to NKE (9.03%). In terms of maximum drawdown, CLOV dropped -97.19% vs NKE's -75.19%.
CLOV currently has the higher Sharpe Ratio (0.64 vs -1.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CLOV and NKE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer